Targeting Cancer with PCPA-Drug Conjugates: LSD1 Inhibition-Triggered Release of 4-Hydroxytamoxifen.

about

Drug conjugates—an emerging approach to treat breast cancer.

P2860

Q55438401-7E122960-4CE8-4234-B3E2-4354CAC04180

P2860

Targeting Cancer with PCPA-Drug Conjugates: LSD1 Inhibition-Triggered Release of 4-Hydroxytamoxifen.

Item

http://www.wikidata.org/entity/Q53664533

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Targeting Cancer with PCPA-Dru ...... Release of 4-Hydroxytamoxifen.

@en

Targeting Cancer with PCPA-Dru ...... Release of 4-Hydroxytamoxifen.

@nl

type

Item

label

Targeting Cancer with PCPA-Dru ...... Release of 4-Hydroxytamoxifen.

@en

Targeting Cancer with PCPA-Dru ...... Release of 4-Hydroxytamoxifen.

@nl

prefLabel

Targeting Cancer with PCPA-Dru ...... Release of 4-Hydroxytamoxifen.

@en

Targeting Cancer with PCPA-Dru ...... Release of 4-Hydroxytamoxifen.

@nl

P1476

Targeting Cancer with PCPA-Dru ...... Release of 4-Hydroxytamoxifen.

@en

P2093

Asako Kaise

http://www.w3.org/2001/XMLSchema#string

Kiminori Ohta

http://www.w3.org/2001/XMLSchema#string

Mitsuharu Masuda

http://www.w3.org/2001/XMLSchema#string

Takayoshi Suzuki

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Sakai

http://www.w3.org/2001/XMLSchema#string

Yasuyuki Endo

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Sowa

http://www.w3.org/2001/XMLSchema#string

Yosuke Ota

http://www.w3.org/2001/XMLSchema#string

P2860

Histone demethylation mediated by the nuclear amine oxidase homolog LSD1

Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine

Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy

Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology

trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1.

High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients.

Quantification of riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in mammalian model cells by CE with LED-induced fluorescence detection.

Lysine-specific demethylase 1-selective inactivators: protein-targeted drug delivery mechanism.

A history of cancer chemotherapy

Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors

P304

16115-16118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANIE.201608711

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yukihiro Itoh

P577

2016-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27882656

http://www.w3.org/2001/XMLSchema#string

Targeting Cancer with PCPA-Drug Conjugates: LSD1 Inhibition-Triggered Release of 4-Hydroxytamoxifen.

about

P2860

P2860

Targeting Cancer with PCPA-Drug Conjugates: LSD1 Inhibition-Triggered Release of 4-Hydroxytamoxifen.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698